25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

DVL (Alliance Pharma plc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Alliance Pharma plc together

I guess you are interested in Alliance Pharma plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Alliance Pharma plc’s Financial Insights
  • 📈 Technical Analysis (TA) – Alliance Pharma plc’s Price Targets

I'm going to help you getting a better view of Alliance Pharma plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Alliance Pharma plc

I send you an email if I find something interesting about Alliance Pharma plc.

1. Quick Overview

1.1. Quick analysis of Alliance Pharma plc (30 sec.)










1.2. What can you expect buying and holding a share of Alliance Pharma plc? (30 sec.)

How much money do you get?

How much money do you get?
€0.09
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€0.48
Expected worth in 1 year
€-0.13
How sure are you?
87.5%

+ What do you gain per year?

Total Gains per Share
€-0.53
Return On Investment
-72.5%

For what price can you sell your share?

Current Price per Share
€0.73
Expected price per share
€0.695 - €0.80393020134228
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Alliance Pharma plc (5 min.)




Live pricePrice per Share (EOD)
€0.73
Intrinsic Value Per Share
€0.29 - €0.80
Total Value Per Share
€0.76 - €1.28

2.2. Growth of Alliance Pharma plc (5 min.)




Is Alliance Pharma plc growing?

Current yearPrevious yearGrowGrow %
How rich?$281.7m$371.9m-$90.2m-32.0%

How much money is Alliance Pharma plc making?

Current yearPrevious yearGrowGrow %
Making money-$42.8m$1.2m-$44m-102.8%
Net Profit Margin-18.3%0.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Alliance Pharma plc (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Alliance Pharma plc?

Welcome investor! Alliance Pharma plc's management wants to use your money to grow the business. In return you get a share of Alliance Pharma plc.

First you should know what it really means to hold a share of Alliance Pharma plc. And how you can make/lose money.

Speculation

The Price per Share of Alliance Pharma plc is €0.73. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Alliance Pharma plc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Alliance Pharma plc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.48. Based on the TTM, the Book Value Change Per Share is €-0.15 per quarter. Based on the YOY, the Book Value Change Per Share is €0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.02 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Alliance Pharma plc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.08-10.9%-0.08-10.9%0.000.3%0.000.5%0.023.0%
Usd Book Value Change Per Share-0.17-22.9%-0.17-22.9%0.011.7%-0.02-2.2%0.078.9%
Usd Dividend Per Share0.023.1%0.023.1%0.023.0%0.022.5%0.022.3%
Usd Total Gains Per Share-0.14-19.7%-0.14-19.7%0.034.7%0.000.2%0.0811.2%
Usd Price Per Share0.44-0.44-0.61-0.90-0.66-
Price to Earnings Ratio-5.55--5.55-274.57-83.45-54.34-
Price-to-Total Gains Ratio-3.05--3.05-17.98-26.02-22.65-
Price to Book Ratio0.84-0.84-0.89-1.37-1.02-
Price-to-Total Gains Ratio-3.05--3.05-17.98-26.02-22.65-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.794313
Number of shares1258
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.020.02
Usd Book Value Change Per Share-0.17-0.02
Usd Total Gains Per Share-0.140.00
Gains per Quarter (1258 shares)-181.152.06
Gains per Year (1258 shares)-724.598.23
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1115-840-73591-83-2
2231-1680-1460182-1656
3346-2520-2185273-24814
4462-3360-2910363-33122
5577-4200-3635454-41330
6693-5040-4360545-49638
7808-5880-5085636-57846
8924-6720-5810727-66154
91039-7560-6535818-74462
101155-8400-7260909-82670

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%7.01.00.087.5%7.01.00.087.5%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%7.01.00.087.5%7.01.00.087.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%8.00.00.0100.0%8.00.00.0100.0%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%7.01.00.087.5%7.01.00.087.5%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Alliance Pharma plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.153-0.1530%0.011-1449%-0.015-90%0.060-356%
Book Value Per Share--0.4790.4790%0.632-24%0.591-19%0.544-12%
Current Ratio--2.5662.5660%2.243+14%2.410+6%1.809+42%
Debt To Asset Ratio--0.4750.4750%0.465+2%0.431+10%0.421+13%
Debt To Equity Ratio--0.9040.9040%0.868+4%0.771+17%0.737+23%
Dividend Per Share--0.0210.0210%0.020+5%0.017+27%0.015+40%
Enterprise Value---15785549.536-15785549.5360%8616899.040-283%200708961.261-108%200703615.695-108%
Eps---0.073-0.0730%0.002-3640%0.004-2131%0.020-461%
Ev To Ebitda Ratio--infinfnan%0.349inf%infnan%infnan%
Ev To Sales Ratio---0.074-0.0740%0.043-270%1.175-106%1.217-106%
Free Cash Flow Per Share--0.0680.0680%0.045+51%0.067+1%0.062+10%
Free Cash Flow To Equity Per Share--0.0680.0680%0.043+58%0.065+4%0.069-3%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.799--------
Intrinsic Value_10Y_min--0.285--------
Intrinsic Value_1Y_max--0.070--------
Intrinsic Value_1Y_min--0.054--------
Intrinsic Value_3Y_max--0.218--------
Intrinsic Value_3Y_min--0.141--------
Intrinsic Value_5Y_max--0.376--------
Intrinsic Value_5Y_min--0.204--------
Market Cap394613191.680+45%218388670.464218388670.4640%305419799.040-28%445318283.981-51%325900493.971-33%
Net Profit Margin---0.183-0.1830%0.006-3380%0.023-910%0.092-300%
Operating Margin----0%0.170-100%0.182-100%0.209-100%
Operating Ratio--1.1931.1930%1.221-2%1.161+3%1.163+3%
Pb Ratio1.524+45%0.8430.8430%0.893-6%1.373-39%1.017-17%
Pe Ratio-10.021-81%-5.546-5.5460%274.574-102%83.450-107%54.337-110%
Price Per Share0.730+45%0.4040.4040%0.565-28%0.824-51%0.603-33%
Price To Free Cash Flow Ratio10.811+45%5.9835.9830%12.620-53%12.233-51%9.727-38%
Price To Total Gains Ratio-5.516-81%-3.053-3.0530%17.983-117%26.025-112%22.655-113%
Quick Ratio--1.2171.2170%0.952+28%0.967+26%0.747+63%
Return On Assets---0.080-0.0800%0.002-4685%0.003-3048%0.025-417%
Return On Equity---0.152-0.1520%0.003-4774%-0.001-100%0.039-489%
Total Gains Per Share---0.132-0.1320%0.031-521%0.002-8903%0.075-276%
Usd Book Value--281731149.269281731149.2690%371973875.284-24%347366995.442-19%319718005.478-12%
Usd Book Value Change Per Share---0.167-0.1670%0.012-1449%-0.016-90%0.065-356%
Usd Book Value Per Share--0.5210.5210%0.688-24%0.643-19%0.591-12%
Usd Dividend Per Share--0.0230.0230%0.022+5%0.018+27%0.016+40%
Usd Enterprise Value---17176256.450-17176256.4500%9376047.845-283%218391420.748-108%218385604.238-108%
Usd Eps---0.079-0.0790%0.002-3640%0.004-2131%0.022-461%
Usd Free Cash Flow--39716213.20139716213.2010%26333941.585+51%39507248.557+1%31662475.333+25%
Usd Free Cash Flow Per Share--0.0730.0730%0.049+51%0.073+1%0.067+10%
Usd Free Cash Flow To Equity Per Share--0.0730.0730%0.047+58%0.071+4%0.075-3%
Usd Market Cap429378613.867+45%237628712.332237628712.3320%332327283.335-28%484550824.800-51%354612327.490-33%
Usd Price Per Share0.794+45%0.4400.4400%0.615-28%0.896-51%0.656-33%
Usd Profit---42848096.653-42848096.6530%1210339.765-3640%2109301.523-2131%11882601.164-461%
Usd Revenue--233636953.867233636953.8670%216485301.465+8%200880452.938+16%177114991.990+32%
Usd Total Gains Per Share---0.144-0.1440%0.034-521%0.002-8903%0.082-276%
 EOD+4 -4MRQTTM+0 -0YOY+15 -245Y+14 -2410Y+12 -26

3.3 Fundamental Score

Let's check the fundamental score of Alliance Pharma plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-10.021
Price to Book Ratio (EOD)Between0-11.524
Net Profit Margin (MRQ)Greater than0-0.183
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.217
Current Ratio (MRQ)Greater than12.566
Debt to Asset Ratio (MRQ)Less than10.475
Debt to Equity Ratio (MRQ)Less than10.904
Return on Equity (MRQ)Greater than0.15-0.152
Return on Assets (MRQ)Greater than0.05-0.080
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Alliance Pharma plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.248
Ma 20Greater thanMa 500.714
Ma 50Greater thanMa 1000.686
Ma 100Greater thanMa 2000.608
OpenGreater thanClose0.730
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About Alliance Pharma plc

Alliance Pharma plc acquires, markets, and distributes consumer healthcare products and prescription medicines in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. It provides its products under the Aloclair, Anbesol, Asthon & Parsons, Forceval, Hydromol, Kelo-Cote, MacuShield, Vamousse, Nizoral, and Amberen brand names. The company was incorporated in 1996 and is headquartered in Chippenham, the United Kingdom.

Fundamental data was last updated by Penke on 2025-03-16 04:44:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Alliance Pharma plc earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -18.3% means that €-0.18 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alliance Pharma plc:

  • The MRQ is -18.3%. The company is making a huge loss. -2
  • The TTM is -18.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-18.3%TTM-18.3%0.0%
TTM-18.3%YOY0.6%-18.9%
TTM-18.3%5Y2.3%-20.6%
5Y2.3%10Y9.2%-6.9%
4.3.1.2. Return on Assets

Shows how efficient Alliance Pharma plc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -8.0% Return on Assets means that Alliance Pharma plc generated €-0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alliance Pharma plc:

  • The MRQ is -8.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.0%TTM-8.0%0.0%
TTM-8.0%YOY0.2%-8.2%
TTM-8.0%5Y0.3%-8.3%
5Y0.3%10Y2.5%-2.2%
4.3.1.3. Return on Equity

Shows how efficient Alliance Pharma plc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • -15.2% Return on Equity means Alliance Pharma plc generated €-0.15 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alliance Pharma plc:

  • The MRQ is -15.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -15.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.2%TTM-15.2%0.0%
TTM-15.2%YOY0.3%-15.5%
TTM-15.2%5Y-0.1%-15.1%
5Y-0.1%10Y3.9%-4.0%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Alliance Pharma plc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Alliance Pharma plc is operating .

  • Measures how much profit Alliance Pharma plc makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alliance Pharma plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY17.0%-17.0%
TTM-5Y18.2%-18.2%
5Y18.2%10Y20.9%-2.8%
4.3.2.2. Operating Ratio

Measures how efficient Alliance Pharma plc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.19 means that the operating costs are €1.19 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Alliance Pharma plc:

  • The MRQ is 1.193. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.193. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.193TTM1.1930.000
TTM1.193YOY1.221-0.028
TTM1.1935Y1.161+0.032
5Y1.16110Y1.163-0.002
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Alliance Pharma plc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Alliance Pharma plc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.57 means the company has €2.57 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Alliance Pharma plc:

  • The MRQ is 2.566. The company is able to pay all its short-term debts. +1
  • The TTM is 2.566. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.566TTM2.5660.000
TTM2.566YOY2.243+0.323
TTM2.5665Y2.410+0.156
5Y2.41010Y1.809+0.601
4.4.3.2. Quick Ratio

Measures if Alliance Pharma plc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 1.22 means the company can pay off €1.22 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alliance Pharma plc:

  • The MRQ is 1.217. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 1.217. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.217TTM1.2170.000
TTM1.217YOY0.952+0.265
TTM1.2175Y0.967+0.250
5Y0.96710Y0.747+0.220
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Alliance Pharma plc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Alliance Pharma plc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Alliance Pharma plc to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.47 means that Alliance Pharma plc assets are financed with 47.5% credit (debt) and the remaining percentage (100% - 47.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Alliance Pharma plc:

  • The MRQ is 0.475. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.475. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.475TTM0.4750.000
TTM0.475YOY0.465+0.010
TTM0.4755Y0.431+0.044
5Y0.43110Y0.421+0.010
4.5.4.2. Debt to Equity Ratio

Measures if Alliance Pharma plc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 90.4% means that company has €0.90 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alliance Pharma plc:

  • The MRQ is 0.904. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.904. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.904TTM0.9040.000
TTM0.904YOY0.868+0.036
TTM0.9045Y0.771+0.134
5Y0.77110Y0.737+0.033
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Alliance Pharma plc generates.

  • Above 15 is considered overpriced but always compare Alliance Pharma plc to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -5.55 means the investor is paying €-5.55 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alliance Pharma plc:

  • The EOD is -10.021. Based on the earnings, the company is expensive. -2
  • The MRQ is -5.546. Based on the earnings, the company is expensive. -2
  • The TTM is -5.546. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.021MRQ-5.546-4.475
MRQ-5.546TTM-5.5460.000
TTM-5.546YOY274.574-280.119
TTM-5.5465Y83.450-88.996
5Y83.45010Y54.337+29.113
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Alliance Pharma plc:

  • The EOD is 10.811. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 5.983. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 5.983. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD10.811MRQ5.983+4.828
MRQ5.983TTM5.9830.000
TTM5.983YOY12.620-6.637
TTM5.9835Y12.233-6.250
5Y12.23310Y9.727+2.506
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Alliance Pharma plc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.84 means the investor is paying €0.84 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Alliance Pharma plc:

  • The EOD is 1.524. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.843. Based on the equity, the company is cheap. +2
  • The TTM is 0.843. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.524MRQ0.843+0.681
MRQ0.843TTM0.8430.000
TTM0.843YOY0.893-0.050
TTM0.8435Y1.373-0.529
5Y1.37310Y1.017+0.356
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Income before Tax  36,931-21,46315,4686,11021,578-15,3896,189-64,183-57,994
Net Income  29,722-20,1839,539-8418,698-7,5861,112-40,491-39,379
Tax Provision  7,209-1,2805,9296,95112,880-7,8035,077-23,692-18,615
Net Income from Continuing Operations  29,722-20,1839,539-8418,698-7,5861,112-40,491-39,379



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets414,923
Total Liabilities197,050
Total Stockholder Equity217,873
 As reported
Total Liabilities 197,050
Total Stockholder Equity+ 217,873
Total Assets = 414,923

Assets

Total Assets414,923
Total Current Assets104,095
Long-term Assets310,828
Total Current Assets
Cash And Cash Equivalents 22,436
Net Receivables 49,371
Inventory 25,711
Total Current Assets  (as reported)104,095
Total Current Assets  (calculated)97,518
+/- 6,577
Long-term Assets
Property Plant Equipment 5,721
Goodwill 14,487
Intangible Assets 285,491
Long-term Assets Other 404
Long-term Assets  (as reported)310,828
Long-term Assets  (calculated)306,103
+/- 4,725

Liabilities & Shareholders' Equity

Total Current Liabilities40,570
Long-term Liabilities156,480
Total Stockholder Equity217,873
Total Current Liabilities
Accounts payable 18,225
Total Current Liabilities  (as reported)40,570
Total Current Liabilities  (calculated)18,225
+/- 22,345
Long-term Liabilities
Long term Debt 113,646
Capital Lease Obligations Min Short Term Debt3,769
Long-term Liabilities Other 199
Long-term Liabilities  (as reported)156,480
Long-term Liabilities  (calculated)117,614
+/- 38,866
Total Stockholder Equity
Retained Earnings 43,366
Total Stockholder Equity (as reported)217,873
Total Stockholder Equity (calculated)43,366
+/- 174,507
Other
Capital Stock5,404
Common Stock Shares Outstanding 540,390
Net Debt 91,210
Net Invested Capital 331,519
Net Working Capital 63,525
Property Plant and Equipment Gross 12,607



6.3. Balance Sheets Structured

Currency in GBP. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
320,737
336,475
403,609
407,637
508,853
503,488
537,411
414,923
414,923537,411503,488508,853407,637403,609336,475320,737
   > Total Current Assets 
49,283
49,127
58,747
65,037
77,239
81,021
105,481
104,095
104,095105,48181,02177,23965,03758,74749,12749,283
       Cash And Cash Equivalents 
7,221
11,184
10,893
17,830
28,898
29,061
31,714
22,436
22,43631,71429,06128,89817,83010,89311,1847,221
       Net Receivables 
24,596
21,230
27,932
30,289
19,834
30,821
44,764
49,371
49,37144,76430,82119,83430,28927,93221,23024,596
       Inventory 
15,356
14,248
18,706
15,518
22,917
21,075
24,286
25,711
25,71124,28621,07522,91715,51818,70614,24815,356
   > Long-term Assets 
271,454
287,348
344,862
342,600
431,614
422,467
431,930
310,828
310,828431,930422,467431,614342,600344,862287,348271,454
       Property Plant Equipment 
1,806
3,309
3,341
11,554
15,921
4,826
5,578
5,721
5,7215,5784,82615,92111,5543,3413,3091,806
       Goodwill 
16,197
16,565
16,565
16,532
31,260
31,238
21,530
14,487
14,48721,53031,23831,26016,53216,56516,56516,197
       Intangible Assets 
248,636
262,058
318,678
312,128
381,612
382,506
400,100
285,491
285,491400,100382,506381,612312,128318,678262,058248,636
       Other Assets 
4,055
4,590
2,793
2,386
2,821
3,897
4,722
0
04,7223,8972,8212,3862,7934,5904,055
> Total Liabilities 
141,474
133,098
151,410
133,457
227,895
221,002
249,750
197,050
197,050249,750221,002227,895133,457151,410133,098141,474
   > Total Current Liabilities 
50,277
61,389
91,723
24,206
30,186
40,577
47,022
40,570
40,57047,02240,57730,18624,20691,72361,38950,277
       Short Long Term Debt 
25,782
41,719
68,035
0
0
0
0
0
0000068,03541,71925,782
       Accounts payable 
5,655
6,662
8,978
6,970
11,275
8,341
35,616
18,225
18,22535,6168,34111,2756,9708,9786,6625,655
       Other Current Liabilities 
6,685
3,865
2,154
2,803
1,868
11,495
0
0
0011,4951,8682,8032,1543,8656,685
   > Long-term Liabilities 
91,197
72,288
59,687
109,251
197,709
180,425
202,728
156,480
156,480202,728180,425197,709109,25159,68772,28891,197
       Long term Debt 
57,554
41,780
28,667
77,040
138,328
116,060
133,744
113,646
113,646133,744116,060138,32877,04028,66741,78057,554
       Capital Lease Obligations Min Short Term Debt
0
0
2,419
3,022
3,695
2,882
3,832
3,769
3,7693,8322,8823,6953,0222,41900
       Other Liabilities 
33,259
30,445
29,043
30,214
56,650
61,939
0
0
0061,93956,65030,21429,04330,44533,259
       Long-term Liabilities Other 
1,817
3,525
380
404
469
2,637
3,415
199
1993,4152,6374694043803,5251,817
       Deferred Long Term Liability 
704
725
768
0
0
0
0
0
00000768725704
> Total Stockholder Equity
179,263
203,377
252,199
274,180
280,958
282,486
287,661
217,873
217,873287,661282,486280,958274,180252,199203,377179,263
   Common Stock
4,726
4,750
5,182
5,294
5,329
5,382
5,400
0
05,4005,3825,3295,2945,1824,7504,726
   Retained Earnings 
60,177
83,089
95,099
112,513
117,703
116,418
108,238
43,366
43,366108,238116,418117,703112,51395,09983,08960,177
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
4,766
5,017
7,279
7,337
7,281
9,358
22,373
0
022,3739,3587,2817,3377,2795,0174,766



6.4. Balance Sheets

Currency in GBP. All numbers in thousands.




6.5. Cash Flows

Currency in GBP. All numbers in thousands.




6.6. Income Statements

Currency in GBP. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in GBP. All numbers in thousands.

Gross Profit (+$)
totalRevenue180,680
Cost of Revenue-75,661
Gross Profit105,019105,019
 
Operating Income (+$)
Gross Profit105,019
Operating Expense-139,870
Operating Income40,810-34,851
 
Operating Expense (+$)
Research Development-
Selling General Administrative54,219
Selling And Marketing Expenses-
Operating Expense139,87054,219
 
Net Interest Income (+$)
Interest Income113
Interest Expense-9,530
Other Finance Cost-461
Net Interest Income-9,878
 
Pretax Income (+$)
Operating Income40,810
Net Interest Income-9,878
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-48,80040,810
EBIT - interestExpense = -9,530
-33,136
-23,606
Interest Expense9,530
Earnings Before Interest and Taxes (EBIT)--39,270
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-48,800
Tax Provision--15,664
Net Income From Continuing Ops-33,136-33,136
Net Income-33,136
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-9,878
 

Technical Analysis of Alliance Pharma plc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Alliance Pharma plc. The general trend of Alliance Pharma plc is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Alliance Pharma plc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Alliance Pharma plc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Alliance Pharma plc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.7745 < 0.7745 < 0.80393020134228.

The bearish price targets are: 0.725 > 0.695 > 0.695.

Tweet this
Alliance Pharma plc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Alliance Pharma plc. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Alliance Pharma plc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Alliance Pharma plc. The current macd is 0.01143424.

The long score for the Moving Average Convergence/Divergence (MACD) is 2/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 0/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alliance Pharma plc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Alliance Pharma plc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Alliance Pharma plc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Alliance Pharma plc Daily Moving Average Convergence/Divergence (MACD) ChartAlliance Pharma plc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Alliance Pharma plc. The current adx is 44.56.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Alliance Pharma plc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Alliance Pharma plc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Alliance Pharma plc. The current sar is 0.69898372.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Alliance Pharma plc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Alliance Pharma plc. The current rsi is 66.25. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Alliance Pharma plc Daily Relative Strength Index (RSI) ChartAlliance Pharma plc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Alliance Pharma plc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Alliance Pharma plc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Alliance Pharma plc Daily Stochastic Oscillator ChartAlliance Pharma plc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Alliance Pharma plc. The current cci is 138.04.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Alliance Pharma plc Daily Commodity Channel Index (CCI) ChartAlliance Pharma plc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Alliance Pharma plc. The current cmo is 36.25.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Alliance Pharma plc Daily Chande Momentum Oscillator (CMO) ChartAlliance Pharma plc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Alliance Pharma plc. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Alliance Pharma plc Daily Williams %R ChartAlliance Pharma plc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Alliance Pharma plc.

Alliance Pharma plc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Alliance Pharma plc. The current atr is 0.00734473.

Alliance Pharma plc Daily Average True Range (ATR) ChartAlliance Pharma plc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Alliance Pharma plc. The current obv is 4,935.

Alliance Pharma plc Daily On-Balance Volume (OBV) ChartAlliance Pharma plc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Alliance Pharma plc. The current mfi is 58.63.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Alliance Pharma plc Daily Money Flow Index (MFI) ChartAlliance Pharma plc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Alliance Pharma plc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-10-22 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-23 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-29 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-30 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-31 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-05 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-06 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-07 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-08 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-14 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-11-18 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-20 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-21 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-22 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-26 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-28 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-02 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-04 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-06 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-10 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-11 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-19 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-20 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-23 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-12-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-30 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-02 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-03 00:00:00WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-06 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-09 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-10 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-14 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-17 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-30 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-03 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-06 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-10 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-11 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-19 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-21 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-24 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-26 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-27 00:00:00WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-10 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-12 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Alliance Pharma plc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Alliance Pharma plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5066.248
Ma 20Greater thanMa 500.714
Ma 50Greater thanMa 1000.686
Ma 100Greater thanMa 2000.608
OpenGreater thanClose0.730
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Alliance Pharma plc with someone you think should read this too:
  • Are you bullish or bearish on Alliance Pharma plc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Alliance Pharma plc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Alliance Pharma plc

I send you an email if I find something interesting about Alliance Pharma plc.


Comments

How you think about this?

Leave a comment

Stay informed about Alliance Pharma plc.

Receive notifications about Alliance Pharma plc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.